Cytokine Signaling and Hematopoietic Homeostasis Are Disrupted in Lnk-deficient Mice

Journal of Experimental Medicine - Tập 195 Số 12 - Trang 1599-1611 - 2002
Laura Evelia Torres Velázquez1, Alec M. Cheng2, Heather E. Fleming3,4, Caren Furlonger3, Shirly M. Vesely5, Alan Bernstein5,6,7, Christopher J. Paige3,4, Tony Pawson5,6
1Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario M5G 1X5, Canada
2Division of Rheumatology, Washington University School of Medicine, St. Louis, MO 63110
34Ontario Cancer Institute, Princess Margaret Hospital, University Health Network
45Departments of Immunology and Medical Biophysics, University of Toronto, Toronto, Ontario M5G 2M9, Canada
51Samuel Lunenfeld Research Institute, Mount Sinai Hospital
62Department of Medical and Molecular Genetics, University of Toronto, Toronto, Ontario M5G 1X5, Canada
76The Canadian Institutes of Health Research, Ottawa, Ontario K1A 0W9, Canada

Tóm tắt

The adaptor protein Lnk, and the closely related proteins APS and SH2B, form a subfamily of SH2 domain-containing proteins implicated in growth factor, cytokine, and immunoreceptor signaling. To elucidate the physiological function of Lnk, we derived Lnk-deficient mice. Lnk−/− mice are viable, but display marked changes in the hematopoietic compartment, including splenomegaly and abnormal lymphoid and myeloid homeostasis. The in vitro proliferative capacity and absolute numbers of hematopoietic progenitors from Lnk−/− mice are greatly increased, in part due to hypersensitivity to several cytokines. Moreover, an increased synergy between stem cell factor and either interleukin (IL)-3 or IL-7 was observed in Lnk−/− cells. Furthermore, Lnk inactivation causes abnormal modulation of IL-3 and stem cell factor–mediated signaling pathways. Consistent with these results, we also show that Lnk is highly expressed in multipotent cells and committed precursors in the erythroid, megakaryocyte, and myeloid lineages. These data implicate Lnk as playing an important role in hematopoiesis and in the regulation of growth factor and cytokine receptor–mediated signaling.

Từ khóa


Tài liệu tham khảo

1996, Annu. Rev. Cell Dev. Biol., 12, 91, 10.1146/annurev.cellbio.12.1.91

1995, Nature., 377, 591, 10.1038/377591a0

1997, Immunity., 7, 1, 10.1016/S1074-7613(00)80505-1

1996, Cell., 84, 331, 10.1016/S0092-8674(00)81277-5

2000, Blood., 95, 19, 10.1182/blood.V95.1.19.001k34_19_29

1993, Cell., 73, 1445, 10.1016/0092-8674(93)90369-2

2000, Mol. Cell., 6, 693, 10.1016/S1097-2765(00)00067-8

2001, Nature., 409, 349, 10.1038/35053086

1998, Pharmacol. Rev., 50, 1

1997, Leuk. Res., 21, 1027, 10.1016/S0145-2126(97)00093-3

1999, Curr. Opin. Cell Biol., 11, 219, 10.1016/S0955-0674(99)80029-5

1996, Blood., 87, 3669, 10.1182/blood.V87.9.3669.bloodjournal8793669

1997, Proc. Natl. Acad. Sci. USA., 94, 11345, 10.1073/pnas.94.21.11345

2001, J. Biol. Chem., 276, 24274, 10.1074/jbc.M009098200

1998, J. Exp. Med., 187, 1893, 10.1084/jem.187.11.1893

1999, Ann. Hematol., 78, 49, 10.1007/s002770050473

2001, J. Exp. Med., 194, 275, 10.1084/jem.194.3.275

2001, J. Exp. Med, 194, 265, 10.1084/jem.194.3.265

1995, Proc. Natl. Acad. Sci. USA., 92, 11618, 10.1073/pnas.92.25.11618

1997, J. Biol. Chem., 272, 14562, 10.1074/jbc.272.23.14562

2000, J. Immunol., 164, 5199, 10.4049/jimmunol.164.10.5199

2000, Immunity., 13, 599, 10.1016/S1074-7613(00)00060-1

1997, Oncogene., 15, 7, 10.1038/sj.onc.1201163

1995, Biotechnology., 13, 1474

1997, J. Biochem (Tokyo)., 122, 1105, 10.1093/oxfordjournals.jbchem.a021868

1998, J. Biol. Chem., 273, 21239, 10.1074/jbc.273.33.21239

1998, Neuron., 21, 1017, 10.1016/S0896-6273(00)80620-0

1998, Biochem. J., 335, 103, 10.1042/bj3350103

1999, J. Biol. Chem., 274, 11186, 10.1074/jbc.274.16.11186

1998, J. Biol. Chem., 273, 3136, 10.1074/jbc.273.6.3136

2000, Biochem. Biophys. Res. Commun., 272, 45, 10.1006/bbrc.2000.2736

1999, Leukemia., 13, 760, 10.1038/sj.leu.2401397

1997, Mol. Cell. Biol., 17, 6633, 10.1128/MCB.17.11.6633

1999, Proc. Natl. Acad. Sci. USA., 96, 7172, 10.1073/pnas.96.13.7172

1999, Oncogene., 18, 759, 10.1038/sj.onc.1202326

1993, Proc. Natl. Acad. Sci. USA., 90, 8424, 10.1073/pnas.90.18.8424

1993, Nature., 365, 87, 10.1038/365087a0

1981, J. Immunol., 127, 2262, 10.4049/jimmunol.127.6.2262

2001, Immunity., 15, 521, 10.1016/S1074-7613(01)00216-3

1991, Mol. Cell. Biol., 11, 3043

2000, Blood., 96, 132, 10.1182/blood.V96.1.132

2001, Blood., 97, 2257, 10.1182/blood.V97.8.2257

1991, J. Exp. Med., 173, 1213, 10.1084/jem.173.5.1213

1998, J. Immunol., 161, 6038, 10.4049/jimmunol.161.11.6038

1997, Curr. Opin. Immunol., 9, 296, 10.1016/S0952-7915(97)80074-X

1991, Blood., 77, 2316, 10.1182/blood.V77.11.2316.2316

1999, Int. J. Biochem. Cell Biol., 31, 1053, 10.1016/S1357-2725(99)00078-3

1990, Agents Actions., 31, 197, 10.1007/BF01997608

1975, Semin. Hematol., 12, 409

1998, J. Clin. Invest., 102, 1951, 10.1172/JCI3729

1999, Oncogene., 18, 7190, 10.1038/sj.onc.1203226

1993, Blood., 81, 1442, 10.1182/blood.V81.6.1442.1442

1997, Proc. Natl. Acad. Sci. USA., 94, 1806, 10.1073/pnas.94.5.1806

1998, Dev. Comp. Immunol., 22, 289, 10.1016/S0145-305X(98)00007-X

1998, Genes Dev., 12, 1610, 10.1101/gad.12.11.1610

1997, Trends Biotechnol., 15, 302, 10.1016/S0167-7799(97)01060-3

1999, Cell., 98, 617, 10.1016/S0092-8674(00)80049-5

1996, Nat. Genet., 13, 309, 10.1038/ng0796-309